Drug intelligence / Profile preview

amoxicillin + metronidazole

Development stage
Preclinical
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**Amoxicillin + metronidazole** is an oral co-administration regimen of two generic small-molecule antibacterial drugs, rather than a single proprietary fixed-dose product. Amoxicillin is a beta-lactam penicillin that irreversibly inhibits bacterial penicillin-binding proteins and thereby disrupts peptidoglycan cell-wall synthesis. Metronidazole is a nitroimidazole prodrug that is reduced preferentially in anaerobic microorganisms to reactive metabolites that damage bacterial DNA. The combination provides complementary aerobic and anaerobic coverage and has been used adjunctively with scaling and root planing for severe, chronic, and aggressive periodontitis, particularly to suppress anaerobic periodontal pathogens.

Brand names
Amoxicillin Sandoz
Other names
amoxicillin + metronidazoleamoxicillin/metronidazoleMET-AMOmetronidazole + amoxicillinmetronidazole/amoxicillin阿莫西林+甲硝唑
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on amoxicillin + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call